News | November 27, 2022
Briefs: IOL Chemicals and Cipla
Government of India has granted a patent for invention entitled "An improved safe process for the preparation of Sartan drugs of Formula I".
Government of India has granted a patent for invention entitled "An improved safe process for the preparation of Sartan drugs of Formula I".
The brand Azmarda fits well with JBCPL's overall strategy of strengthening its presence in the cardiology segment in India.
The Cidmus brand shall be affixed on the pharmaceutical composition comprising a combination of Valsartan and Sacubitril (currently under Novartis patent) which is indicated for heart failure patients with reduced ejection fraction
ICICI Direct analysis of Dr Reddy’s Q3FY22 results
The injunction order has been passed against Natco Pharma, Torrent Pharmaceuticals, Eris Lifesciences and Windlas Biotech
The company will engage with the agency to resolve the import alert at the earliest and ensure cGMP compliance.
Subscribe To Our Newsletter & Stay Updated
